Spain (ES)

Brain tissue mechanics is governed by microscale relations of the tissue constituents (2023) Sáez P, Borau C, Antonovaite N, Franze K Journal article Preparation and characterization of novel poly (lactic acid)/calcium oxide nanocomposites by electrospinning as a potential bone tissue scaffold (2023) Canales D, Moyano D, Alvarez F, Grande-Tovar CD, Valencia-Llano CH, Peponi L, Boccaccini AR, Zapata PA Journal article 3D-Shaped Binders of Unfolded Proteins Inducing Cancer Cell-Specific Endoplasmic Reticulum Stress In Vitro and In Vivo (2023) Klemt I, Varzatskii O, Selin R, Vakarov S, Kovalska VB, Bila G, Bilyy R, et al. Journal article Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion (2023) Rejeski K, Perez A, Iacoboni G, Blumenberg V, Bücklein VL, Völkl S, Penack O, et al. Journal article UNSTAINED WHITE BLOOD CELL CLASSIFICATION USING DEEP LEARNING (2023) Yu H, Forster F, Bhandary Panambur A, Merino A, Maier A, Marquardt G Conference contribution Improving Oxygen Reduction Reaction ORR Fuel Cell Efficiency with Carbon Nano Onions (2023) Steiger F, Kaiser P, Assebban M, Hirsch A, Abellan G, Echegoyen L, Mayrhofer KJJ, et al. Conference contribution The first Miocene fossils from coastal woodlands in the southern East African Rift (2023) Bobe R, Aldeias V, Alemseged Z, Anemone RL, Archer W, Aumaître G, Bamford MK, et al. Journal article Diabetes and factors associated with cognitive and functional decline. The screening for CKD among older people across Europe (SCOPE) study (2023) Formiga F, Badía-Tejero AM, Corsonello A, Ärnlöv J, Carlsson AC, Mattace-Raso F, Tap L, et al. Journal article, Original article Laboratory and free-living gait performance in adults with COPD and healthy controls (2023) Buekers J, Megaritis D, Koch S, Alcock L, Ammour N, Becker C, Bertuletti S, et al. Journal article Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study (2023) Hurvitz SA, Bardia A, Quiroga V, Park YH, Blancas I, Alonso-Romero JL, Vasiliev A, et al. Journal article